FHS Researchers Develop Multi-Biomarker Panel to Predict Risk of Chronic Kidney Disease

In a study involving more than 2,300 participants from the Framingham Heart Study, researchers identified B-type natriuretic peptide, homocysteine, and aldosterone as biomarkers capable of adding information to traditional CKD risk factors like hypertension and diabetes.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.